Aims We compared invasive (on-site coronary angioplasty or emergency air-ambulance transfer for bypass grafting surgery) vs conservative (persistent medical treatment) strategies in the management of refractory unstable angina in geographically isolated hospitals without cardiac surgical facilities.
Introduction
Invasive management, although indicated for the management of refractory unstable angina [1] , is often underused due to the unavailability of appropriate facilities (fewer than 10% of hospitals in Europe are equipped to perform coronary angioplasty and even less have cardiac surgery back-up on site) [2] .
In hospitals without on-site cardiac surgery the management of refractory unstable angina is restricted to one of the four following strategies: (1) persistence with medical treatment, (2) diagnostic catheterization on-site and urgent transfer to centres with cardiac surgery for further management, (3) transportation to centres with cardiac surgery for diagnostic angiography and possible urgent revascularization or (4) interventional treatment on-site in cases where angioplasty is regarded feasible and transportation to cardiac surgery centres for those patients requiring coronary artery bypass grafting surgery.
Transportation of patients with unstable angina usually does not pose significant problems in geographically compact areas [3] and as a result the second and third of the above proposed strategies are possibly preferable in such regions. In geographically isolated areas, however, transportation is problematic and sometimes not feasible. Thus, either persistence with medical treatment or interventional revascularization by experienced personnel in stand-alone angioplasty units could be the more attractive alternative approaches. Crucial to the question of viability of such units are both the need for surgical back-up during coronary angioplasty and the inherent danger of transportation of unstable patients. European registries have shown that the need for bailout cardiac surgery during angioplasty was 0·7% in 1994 [4] , while the current rates are postulated to be lower due to improved technology and increased use of stents [5] . Also diagnostic and therapeutic interventional procedures in selected stable [6] and unstable patients [7, 8] have been recently reported to be successful and safe in hospitals without on-site cardiac surgery, while the results of primary angioplasty performed in small standalone units compared well with those of centres with on-site surgical facilities [9] [10] [11] [12] . For unstable angina patients, however, there is no reported experience regarding the safety of angioplasty in isolated hospitals without cardiac surgery on-site. The aim of the Treatment of Refractory Unstable angina in geographically isolated areas without Cardiac Surgery (TRUCS) study was to compare an invasive (on site coronary angioplasty or emergency air ambulance transfer for urgent coronary artery bypass grafting surgery) vs a conservative strategy (persistence with medical management) in the management of refractory unstable angina in geographically isolated hospitals without cardiac surgery facilities.
Methods

Study organization
The TRUCS study was a prospective randomized study comparing an invasive vs a conservative strategy on an intention-to-treat basis. The study was organized in Northwestern Greece and the two existing General District Hospitals of the area participated. The two hospitals have a catchment area of 380 000 inhabitants. At the time the study took place there were no cardiac surgical facilities on site. The area is geographically isolated (480 km, 6 h driving distance and 1 h air ambulance time to the nearest cardiac surgical centre). The TRUCS study began enrolment on 1 March 1997 after the ethical committees of the two participating hospitals approved the protocol. The enrolment of the patients ended on 31 October 1998.
Patient eligibility
Eligible patients were those admitted to the Coronary Care Units with class IIIb (primary unstable angina) and IIIc (post-infarction angina) unstable angina [1] , did not suffer a new myocardial infarction or death within the first 48 h post admission and subsequently developed refractory unstable angina. Refractory unstable angina was defined as failure to become asymptomatic (typical chest pain lasting >5 min with or without ECG changes) despite 'optimal' medical treatment after 48 h of initiation of treatment or as recurrence of chest pain with or without ECG changes during hospitalization. Patients refusing to give informed consent were excluded.
Randomization
Eligible patients who were not excluded were randomized to group A (invasive approach) and group B (conservative approach) after giving informed consent.
Treatments
All patients admitted to the Coronary Care Unit with class IIIb and IIIc unstable angina, were treated for 48 h with aspirin, unfractionated or low molecular weight heparin (choice of treating physician), intravenous nitrate infusion, calcium antagonists and beta-blockers, unless contraindicated. Angiotensin converting-enzyme inhibitors and aggressive antidiabetic treatment were administered according to current treatment guidelines. Aggressive lipid lowering treatment was initiated usually after 48 h and at the time that the patients were transferred to the ward. Patients who remained symptomatic after 48 h of antianginal treatment were characterized as having refractory angina.
Group A patients (invasive approach)
All group A patients (invasive approach) underwent coronary angiography locally, the day the diagnosis of refractory unstable angina was made. This was followed, if appropriate, by an immediate revascularization procedure (i.e., on-site coronary angioplasty or bypass grafting at the nearest cardiac surgery centre after the patient was air transferred). Revascularization was recommended in all patients with an obstruction of at least 70% of the diameter of any artery supplying a substantial proportion of the myocardium. Percutaneous coronary intervention was recommended if there were one or two target lesions, and coronary artery bypass surgery was preferred in patients with three-vessel or left main artery disease (flexible reference to ACC/AHA guidelines [13, 14] ). Intravenous glycoprotein IIb/IIIa receptor inhibitors, intracoronary stent insertion and intra-aortic balloon pump were used as adjunct therapy to coronary angioplasty as required.
Group B patients (conservative approach)
All group B patients (conservative approach) continued to be treated medically on the initial 'optimal' therapy The TRUCS study 1955 regime with gradually increasing doses of nitrates and calcium antagonists unless contraindicated. The patients remaining in a refractory ischaemic condition for 5 days were subsequently dealt with invasively (similar to group A). These patients were considered as 'non-stabilized' irrespective of the final outcome.
Follow-up
Patients were seen 1 and 12 months after discharge in the outpatient clinic.
End-points
Primary end-points were in-hospital stabilization, major combined cardiac events (new non-fatal myocardial infarction and death) and duration of hospitalization. Secondary end-points were: readmission for unstable angina, need for late coronary angiography and late revascularization (coronary angioplasty and coronary artery bypass grafting surgery). Stabilization was defined as not having an outcome of myocardial infarction or death during admission. In addition, group B patients were considered as non-stabilized if they required coronary angiography for refractory anginal symptoms during hospitalization. Myocardial infarction was defined by the occurrence of two of the three conventional criteria -typical chest pain, diagnostic electrocardiography recording (mainly new Q-wave), or a raised biochemical marker of myocardial damage according to the following definitions. For non-procedure related myocardial infarction: concentration of CK-MB mass higher than the hospitals' diagnostic limit for myocardial infarction at one measurement. For myocardial infarction in relation to percutaneous coronary interventions: CK-MB mass 1·5 times to the hospitals' diagnostic limit for myocardial infarction at one measurement. Only new Q waves were used for the diagnosis of myocardial infarction in association with coronaryartery bypass surgery. Unstable angina was defined as typical chest pain at rest or minimal exertion with or without ECG changes requiring hospitalization. The duration of hospitalization was calculated from the day of admission to the day of discharge (days of hospitalization after bypass grafting surgery were also included). Late coronary angiography and revascularization procedure was defined as that having occurred after hospital discharge.
Statistical analysis
The two groups were compared on an intention-to-treat analysis. All data were expressed as mean value standard deviation. The unpaired two-tailed Student's t-test was used to compare mean values, while categorical variables were compared using the chi square test. A P<0·05 was considered statistically significant.
Results
Study population
During the study period, 719 consecutive patients were admitted with class IIIb and IIIc unstable angina. One hundred and fifty two of 719 patients developed refractory symptoms. One hundred and forty eight out of 152 eligible patients (males: 108, mean age SD: 62·6 9·5 years) were enrolled in the study (invasive strategy: 76, conservative strategy: 72), while four out of 152 refused to give informed consent and were excluded. The baseline characteristics of the patients are shown in Table 1 .
In-hospital management
The initial medical management in the two groups was similar ( Table 2 ). All group A patients underwent coronary angiography, 40 of 76 (53%) underwent urgent coronary angioplasty, 19 of 76 (25%) were transferred by emergency air ambulance for bypass grafting surgery and 17 of 76 (22%) continued on medical treatment (Table 2 ). Although all group B patients were intended to be treated medically 27 out of 72 (38%) were managed (17) invasively due to persistent refractory symptoms [coronary angiography: 27 (38%), coronary angioplasty: 23 (32%), bypass grafting surgery following emergency air transfer: 4 (6%)] ( Table 2) .
Use of IIb/IIIa inhibitors, stents and intra-aortic balloon pump
IIb/IIIa inhibitors, as adjunct treatment to coronary angioplasty, were used in 38/40 (95%) group A and in 22/23 (96%) group B patients. Intracoronary stents were implanted in 33/40 (85%) group A and 20/23 (85%) group B patients, while intra-aortic balloon pump was used in 3/40 (7·5%) group A patients.
End-point analyses
The end-point analyses are summarized in Table 3 . In-hospital stabilization in groups A and B was achieved in 73 of 76 (96%) and 31 of 72 (43%) patients, respectively (P=0·0001). During hospitalization the combined event rate in group A was 3·9% [three major cardiac 
Analysis of major cardiac events
In group A during hospitalization there was one death (a patient who continued on medical treatment after diagnostic angiography) and two non-fatal myocardial infarctions (Q wave MI: one, non-Q wave MI: one, in patients who underwent coronary angioplasty). In group B there were six inhospital deaths (five prior to any intervention, one following in-house angioplasty). Three of these six deaths were due to fatal myocardial infarctions. Three group B patients suffered from non-fatal myocardial infarctions (Q wave myocardial infarction: 2, non-Q wave myocardial infarction: 1) during hospitalization (all prior to intervention). The total incidence of in-hospital death and myocardial infarction related to urgent angioplasty in these two groups of patients was 1·6% (1/63) and 3·1% (2/63), respectively. No patient suffered any major cardiac event during air transportation, although one was transferred in cardiogenic shock requiring intra-aortic balloon pumping. There was no need for urgent bypass surgery grafting in patients who underwent in-house coronary angioplasty. None of the 23 patients (group A: 19, group B: 4) who underwent coronary artery bypass grafting surgery suffered in-hospital death. However, 2 out of these 23 patients (both in group A) died soon after discharge on days 28 and 32 due to perioperative stroke and heart failure.
Discussion
Patients with refractory unstable angina should be treated with either coronary angioplasty or coronary bypass grafting surgery. However, such management is limited by the availability of facilities and technical staff to perform coronary interventional and surgical procedures. One possible solution to this problem is the transportation of unstable angina patients to tertiary centres with both interventional and surgical facilities. Transportation of such patients is feasible in geographically compact areas where transportation times are short. Modern ambulances can carry much of the necessary equipment and modern intra-aortic balloon pumps are easily portable and have a battery life of hours. With appropriate escorts, transferal of even very ill patients is possible [3] . In geographically isolated areas, however, transportation is problematic and sometimes not feasible. Frequent use of the air-ambulance service (in our case 148 patients would have been transferred during a 20 months period -1·7 patients per week) is expensive, possibly dangerous and requires a great deal of organization. Also there is no experience regarding the safety of air ambulance transfer of unstable angina patients.
Under such circumstances there is a case for small volume, stand-alone angioplasty units, dealing with the interventionally manageable cases, thus reducing the number of patients requiring air transportation. Such units already exist managing only acute myocardial infarction patients. Their results compare well with those from large volume centres, suggesting that the lack of cardiac surgery per se does not limit the application, safety or efficacy of angioplasty in these patients [9] [10] [11] [12] . There is no reported experience, regarding the treatment of unstable angina patients in geographically isolated centres without on-site cardiac surgery facilities.
The TRUCS study is the first randomized prospective clinical trial comparing an invasive (on-site coronary angioplasty or emergency air ambulance transfer for urgent bypass grafting) vs conservative strategy (persistence with medical treatment) in refractory unstable angina in geographically isolated areas without cardiac surgery. Three previously reported large randomized trials (TIMI 3B, VANQWISH and FRISC-II) have evaluated the role of a routine early invasive strategy vs conservative strategy in patients with unstable angina [15] [16] [17] . All patients with refractory symptoms were excluded from these studies and managed invasively. The TRUCS study showed that the combination of on-site coronary angioplasty and emergency air ambulance transfer for urgent bypass grafting offers advantages over persistence with medical treatment in this high risk group of patients. Subjects treated invasively had a lower incidence of death and non-fatal myocardial infarction during hospitalization and at 30 days. Mortality at 12 months in the invasively treated group of the current study was similar to that reported in the TIMI IIIB and FRISC-II trials (3·9% vs 4·1% and 2·2%, respectively) [15, 17] . It should be noted, that the sample size in our study was rather small and that a single additional major cardiac event in group A or one major cardiac event less in group B would have resulted in a non-statistically significant result. This difference, however, is not likely due to chance, because the incidence of death and myocardial infarction in the conservatively treated group was expected to be higher than that reported. The somewhat surprisingly low incidence of myocardial infarction and death in subjects assigned to conservative treatment (which by definition already had failed) was possibly due to the high percentage of cross-over to invasive treatment in these patients. At 12 months follow-up mortality and combined outcome tended to be lower in group A patients, although there was no difference in non-fatal myocardial infarction between the two groups. In the current study, the duration of initial hospitalization, subsequent hospital admissions for unstable angina as well as the number of patients who underwent, after the initial discharge, any revascularization procedure (coronary angioplasty and coronary artery bypass grafting surgery) was not different in the two groups. Our results support the case of stand-alone interventional units in isolated areas for the treatment of refractory unstable angina patients. Angioplasty, using the currently available technology (mounted low profile, flexible stents, IIb/IIIa antagonists, intra-aortic balloon pumping) can be performed safely (incidence of death and myocardial infarction 1·6% and 3·2% respectively) in centres without surgical back-up facilities on site or at close proximity. No deaths or non-fatal MI occurred during patient transfer for urgent CABG (even in patients requiring intra-aortic balloon pumping) making it a feasible alternative when an air ambulance service is available and weather permits.
Transfer for emergency PTCA was not tested in this study. However with such a policy the added cost and strain on the emergency air ambulance resources would certainly be a limiting factor along with unknown consequences on patient safety.
Conclusions
Invasive treatment of patients with refractory angina in remote areas without surgical back-up results in a significant increase of the in-hospital stabilization rate and a reduction in major events in hospital, at 30-days and at 12-months. The present study suggests coronary angioplasty in a stand alone angioplasty unit as well as air transfer of unstable angina patients are safe.
